The case for & against
Bull & Bear analysis
Emerson Electric Co. (NYSE: EMR) is a leading global technology and engineering company specialized in automation solutions, including process controls and software, environmental and residential solutions. The company occupies a strong position in the industrial sector, focusing on digitization and automation trends, particularly in power generation, LNG, and semiconductor industries. Emerson's commitment to technology and innovation enables it to capitalize on ongoing market transformations.
Bull says
- ↑Q3 revenue of $4.87B up 7% YoY on broad-based order growth
- ↑Adjusted EPS $1.71, 13% YoY increase, beat consensus
- ↑Backlog at $8.2B; semiconductor orders jumped 70%, overall orders +7%
- ↑Free cash flow $1.3B (+36% YoY), aided by $82M tariff refunds
- ↑Returned $2.2B to shareholders via buybacks and $0.555 dividend
- ↑Strong automation position in semis/LNG; positive earnings revisions
Bear says
- ↓P/E ratio 35.6× vs fair value 33.4× suggests limited upside
- ↓Middle East uncertainty could disrupt orders and revenue
- ↓High short interest reflects market skepticism and volatility risk
- ↓Tariff policy shifts may raise costs and squeeze margins
- ↓Competitive pricing in power and semis risks margin compression
- ↓Negative profitability and growth metrics imply potential headwinds
Investment themes with EMR
Companies paying above-average dividends
Stocks with high volatility relative to market
Earnings Call · Q1 2024 · Mgmt. Guidance
Transcript signals
Bull points
- Our first quarter results demonstrate, the underlying strength of the markets we serve, the meaningfulness of our differentiated technology and the relentless execution of our global teams.
- Adjusted EPS was $1.22 up 56% versus 2023. And free cash flow was $367 million, up 51%.
- our current strategic project funnel grew by approximately $200 million to $10.4 billion, and our growth programs continue to represent nearly two-thirds of this funnel.
Bear points
- Discrete automation was down low single digits as expected.
- AspenTech sales and ACV were slightly weaker than our expectations for Q1 driven mainly by a delay in renewal from one customer.
- we expect modest adjusted EBITDA expansion as we recognize the cost synergies.